← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Hbvtech
Germantown, MD
$3,021,295
Total funding
5
Grants
Funding over time
peak $1.5M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,021,295 · 5
By mechanism
N01$1,549,999 · 1
N43$912,546 · 2
R43$300,000 · 1
R34$258,750 · 1
Investigators at Hbvtech
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION$1,499,999
N01 · FY2022 · AI
Evaluating HBVZ10-Based Therapies for cccDNA Clearance: Virological Foundation and Synergistic Combinations$606,178
N43 · FY2025 · AI
A New HBV Drug For Establishing Durable Antiviral Efficacy of HBV Treatment$300,000
R43 · FY2021 · AI
Development of a Novel HBV Drug$299,868
N43 · FY2020 · AI
A development strategy to obtain IND approval of HBVZ10, a new HBV cure therapy candidate$258,750
R34 · FY2025 · AI
ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION$50,000
N01 · FY2023 · AI
Development of a Novel HBV Drug$6,500
N43 · FY2021 · AI